Blood protein clues could predict sepsis in cancer patients

NCT ID NCT07277387

Recruiting now Knowledge-focused Sponsor: Instituto de Investigación Biomédica de Salamanca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at blood samples from 350 adults with blood cancer who develop a fever and have very low white blood cells (a condition called febrile neutropenia). The goal is to find patterns of proteins in the blood that can predict if a patient will develop serious complications like sepsis. By identifying these protein patterns early, doctors may be able to treat patients more quickly and effectively.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEBRILE NEUTROPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Febrile Neutropenia hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm Sepsis toxic shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FEBRILE NEUTROPENIA

Contacts and locations

Locations

Complejo Asistencial Universitario de Salamanca
RECRUITING

Salamanca, Salamanca, 37007, Spain
Hospital Universitari Vall d'Hebron
NOT_YET_RECRUITING

Barcelona, Barcelona, Spain
Hospital Universitario Virgen Macarena
NOT_YET_RECRUITING

Seville, Sevilla, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.